Novel approaches to treating type 2 diabetes Michael A. Nauck Commentary 04 December 2015 Pages: 227 - 228
G protein-coupled receptors as new therapeutic targets for type 2 diabetes Frank ReimannFiona M. Gribble Mini-review Open access 12 December 2015 Pages: 229 - 233
Night-time blood pressure: a role in the prediction and prevention of diabetes? Martin K. Rutter Commentary 02 December 2015 Pages: 234 - 236
Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies Eileen MorganSophia R. HallidayChris C. Patterson Meta-Analysis Open access 12 November 2015 Pages: 237 - 243
Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention Ramón C. HermidaDiana E. AyalaJosé R. Fernández Article 23 September 2015 Pages: 244 - 254
Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial Ramón C. HermidaDiana E. AyalaJosé R. Fernández Article 23 September 2015 Pages: 255 - 265
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise Michael A. NauckMurray W. StewartMarc Rendell Article Open access 17 November 2015 Pages: 266 - 274
The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study Marlene Ø. KragLotte HasselbalchNiels de Fine Olivarius Article 26 November 2015 Pages: 275 - 285
Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus Florian C. BonkeEwan DonnachieMichael Mehring Article 30 October 2015 Pages: 286 - 293
Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients Mara CataniDenise WaltherAnne Eugster Short Communication 22 October 2015 Pages: 294 - 298
Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS) Shona J. LivingstoneHelen C. LookerHelen M. Colhoun Article Open access 17 November 2015 Pages: 299 - 306
Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis Min XuXiaofei LvGuang Ning Article 29 October 2015 Pages: 307 - 315
Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models Fang ChenMin ShaXiao Han Article 12 November 2015 Pages: 316 - 324
Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients Enrica FavaroAndrea CarpanettoMaria M. Zanone Article 23 November 2015 Pages: 325 - 333
Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes Carolyn C. RichardsonKerry A. McLaughlinMichael R. Christie Article Open access 13 November 2015 Pages: 334 - 340
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans Manoj AmrutkarMatthias KernMargit Mahlapuu Article 09 November 2015 Pages: 341 - 353
RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice Xiang MaZan ZhouYi Liu Article 13 November 2015 Pages: 354 - 362
Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes Vivi R. SteenbergSigne M. JensenJens J. Holst Article 05 November 2015 Pages: 363 - 370
Cardiac 82Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes Bernt J. von ScholtenPhilip HasbakTine W. Hansen Article 02 November 2015 Pages: 371 - 378
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy Jay C. JhaVicki Thallas-BonkeKarin A. Jandeleit-Dahm Article 28 October 2015 Pages: 379 - 389
Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: a role for slow-wave sleep? Christian Benedict Letter 15 October 2015 Pages: 390 - 391
Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention Ramón C. HermidaDiana E. AyalaJosé R. Fernández Letter 07 December 2015 Pages: 392 - 394
Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial Ramón C. HermidaDiana E. AyalaJosé R. Fernández Erratum 06 November 2015 Pages: 395 - 395
Erratum to: Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals Ghadi AntounFiona McMurrayMary-Ellen Harper Erratum 26 November 2015 Pages: 396 - 397
